Author: Gary Kopycinski

Summer Infant Expands Recall to Replace Video Monitor Rechargeable Batteries Due to Burn Hazard

Washington, DC–(ENEWSPF)–April 24, 2014. Consumers should stop using this product unless otherwise instructed. It is illegal to resell or attempt to resell a recalled consumer product. Recall date: April 23, 2014 Recall number: 14-156 Label on Back of Battery with Battery Number S/N JNS150A Recall Summary Name of product:  Rechargeable[Read More…]

Remington Electric Leaf Blowers Recalled by MTD Due to Laceration Hazard

Washington, DC–(ENEWSPF)–April 24, 2014.  Consumers should stop using this product unless otherwise instructed. It is illegal to resell or attempt to resell a recalled consumer product. Recall date: April 22, 2014 Recall number: 14-152 Recalled Remington electric blower Recall Summary Name of product:  Remington electric leaf blowers Hazard:  The blower’s[Read More…]

Troy-Bilt Electric Leaf Blowers Recalled by MTD Due to Laceration Hazard

Washington, DC–(ENEWSPF)–April 24, 2014.  Consumers should stop using this product unless otherwise instructed. It is illegal to resell or attempt to resell a recalled consumer product. Recall date: April 22, 2014 Recall number: 14-151 Recalled Troy-Bilt electric blower. Recall Summary Name of product:  Troy-Bilt electric leaf blowers Hazard:  The blower’s[Read More…]

Amedisys Home Health Companies Agree to Pay $150 Million to Resolve False Claims Act Allegations

Washington, DC–(ENEWSPF)–April 23, 2014.  Amedisys Inc. and its affiliates (Amedisys) have agreed to pay $150 million to the federal government to resolve allegations that they violated the False Claims Act by submitting false home healthcare billings to the Medicare program, the Department of Justice announced today.  Amedisys, a Louisiana-based for-profit[Read More…]

Pennsylvania Firm and Chief Officer Charged with Shipping Machinery to Iran in Violation of U.S. Export License Requirements

Washington, DC—(ENEWSPF)—April 23, 2014. A criminal information has been filed against a Pennsylvania firm and its chief officer, charging them with conspiracy to evade export reporting requirements and with attempting to smuggle to Iran a lathe machine in violation of U.S. export regulations.   The announcement was made today by the[Read More…]

FDA Approves Sylvant for Rare Castleman’s Disease

Silver Spring, Maryland—(ENEWSPF)—April 23, 2014. The U.S. Food and Drug Administration today approved Sylvant (siltuximab) to treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes). MCD causes an abnormal overgrowth of immune cells in lymph nodes and related tissues in the[Read More…]

Most read stories this week

Take a Survey

ARCHIVES